SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-026511
Filing Date
2021-05-14
Accepted
2021-05-14 17:05:34
Documents
95
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2020_nlspharmaceutics.htm 20-F 1762972
2 DESCRIPTION OF SECURITIES f20f2020ex2-1_nlspharma.htm EX-2.1 135478
3 LICENSE AGREEMENT BY AND BETWEEN NLS PHARMACEUTICS LTD. AND NOVARTIS PHARMA AG, f20f2020ex4-6_nlspharma.htm EX-4.6 198323
4 SUBSIDIARY f20f2020ex8-1_nlspharma.htm EX-8.1 1241
5 CERTIFICATION f20f2020ex12-1_nlspharma.htm EX-12.1 6925
6 CERTIFICATION f20f2020ex12-2_nlspharma.htm EX-12.2 6924
7 CERTIFICATION f20f2020ex13-1_nlspharma.htm EX-13.1 2862
8 CERTIFICATION f20f2020ex13-2_nlspharma.htm EX-13.2 2866
15 GRAPHIC ex4-6_001.jpg GRAPHIC 230428
16 GRAPHIC ex4-6_002.jpg GRAPHIC 96137
17 GRAPHIC ex4-6_003.jpg GRAPHIC 97435
18 GRAPHIC ex4-6_004.jpg GRAPHIC 13491
19 GRAPHIC image_001.jpg GRAPHIC 92638
20 GRAPHIC image_002.jpg GRAPHIC 56905
21 GRAPHIC image_003.jpg GRAPHIC 85480
22 GRAPHIC image_004.jpg GRAPHIC 82749
23 GRAPHIC image_005.jpg GRAPHIC 35702
24 GRAPHIC image_006.jpg GRAPHIC 43657
25 GRAPHIC image_007.jpg GRAPHIC 25128
26 GRAPHIC image_008.jpg GRAPHIC 55758
27 GRAPHIC image_009.jpg GRAPHIC 36948
28 GRAPHIC image_010.jpg GRAPHIC 41627
29 GRAPHIC image_011.jpg GRAPHIC 130296
30 GRAPHIC image_012.jpg GRAPHIC 63289
  Complete submission text file 0001213900-21-026511.txt   7048297

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE nlsp-20201231.xml EX-101.INS 701401
10 XBRL SCHEMA FILE nlsp-20201231.xsd EX-101.SCH 60952
11 XBRL CALCULATION FILE nlsp-20201231_cal.xml EX-101.CAL 26801
12 XBRL DEFINITION FILE nlsp-20201231_def.xml EX-101.DEF 198240
13 XBRL LABEL FILE nlsp-20201231_lab.xml EX-101.LAB 398199
14 XBRL PRESENTATION FILE nlsp-20201231_pre.xml EX-101.PRE 210034
Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address ALTER POSTPLATZ 2 STANS V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39957 | Film No.: 21925820
SIC: 2834 Pharmaceutical Preparations